Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ionita, Cristian
PIONEER-PEDS1, NCT04396236 / 2019-004378-24: A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine	Recruiting	3	1633	Europe, Japan, US, RoW	Lasmiditan, LY573144, Placebo	Eli Lilly and Company	Migraine	01/25	01/25
PIONEER-PEDS2, NCT04396574 / 2019-004379-38: A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine	Recruiting	3	1000	Europe, Japan, US, RoW	Lasmiditan, LY573144	Eli Lilly and Company	Migraine	03/26	03/26
NCT04174157: Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)	Recruiting	N/A	700	Europe, Japan, US, RoW	Prospective observational registry, Zolgensma	Novartis Pharmaceuticals, United BioSource, LLC	Spinal Muscular Atrophy (SMA)	06/38	06/38
Tsao, Catherine
RESILIENT, NCT05337553 / 2022-000193-25: A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy	Active, not recruiting	3	269	Europe, US, RoW	taldefgrobep alfa, BHV-2000, BMS-986089, Placebo	Biohaven Pharmaceuticals, Inc., Biohaven Pharmaceuticals, Inc, Biohaven Pharmaceuticals, Inc.	Spinal Muscular Atrophy, Neuromuscular Diseases, SMA	01/25	01/25
NCT04174157: Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)	Recruiting	N/A	700	Europe, Japan, US, RoW	Prospective observational registry, Zolgensma	Novartis Pharmaceuticals, United BioSource, LLC	Spinal Muscular Atrophy (SMA)	06/38	06/38
Fernandez, Amanda
CDLink, NCT04972604: CureDuchenne Link®: A Resource for Research	Recruiting	N/A	5000	US		CureDuchenne	Duchenne Muscular Dystrophy, Becker Muscular Dystrophy	07/31	07/31
NCT04174157: Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)	Recruiting	N/A	700	Europe, Japan, US, RoW	Prospective observational registry, Zolgensma	Novartis Pharmaceuticals, United BioSource, LLC	Spinal Muscular Atrophy (SMA)	06/38	06/38